Skip to content

Clinical trials

Phase 2 Erectile Dysfunction trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Erectile Dysfunction Phase: Phase 2 Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20053
20061
20081
20102
20112
20131
20152
20171
20181
20191
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Johns Hopkins University2
American Medical Systems1
Beth Israel Deaconess Medical Center1
Dong-A PharmTech Co., Ltd.1
Eisai Inc.1
M.D. Anderson Cancer Center1
Mohit Khera1
NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)1
POM Wonderful LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Erectile Dysfunction20
Hypogonadism4
Prostatic Neoplasms4
Sexual Dysfunction, Physiological3
Ejaculatory Dysfunction1
Epilepsy1
Multiple Endocrine Neoplasia Type 11
Radiation Injuries1
Seizures1
Sexual Dysfunctions, Psychological1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.